Steve Weitman
Impact in
- Pharmaceutical Science top 1%
- Advanced Drug Delivery Systems
- Molecular Medicine top 2%
- Hydrogels: synthesis, properties, applications
Papers in
-
- Drug Solubulity and Delivery Systems 3
- Advanced Drug Delivery Systems 3
- Oncology 8
- Cancer Treatment and Pharmacology 4
- Co-authors
- Peter L. Bonate (9 shared papers)Daniel D. Von Hoff (4 shared papers)Rubén M. Muñoz (1 shared paper)David J. Bearss (1 shared paper)Haiyong Han (1 shared paper)Laurence H. Hurley (1 shared paper)Cory L. Grand (1 shared paper)Zina Moldoveanu (1 shared paper)
- Journals
- Clinical Cancer Research (3 papers)Cancer Chemotherapy and Pharmacology (2 papers)Journal of Pediatric Hematology/Oncology (2 papers)Journal of Clinical Oncology (2 papers)Blood (1 paper)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Steve Weitman
34 papers receiving 2.5k citations
Peers
Comparison fields: 5 of 103
- Pharmaceutical Science 407
- Molecular Medicine 275
- Cell Biology 198
- Biomaterials 163
- Molecular Biology 734
Countries citing papers authored by Steve Weitman
This map shows the geographic impact of Steve Weitman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steve Weitman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steve Weitman more than expected).
Fields of papers citing papers by Steve Weitman
This network shows the impact of papers produced by Steve Weitman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steve Weitman. The network helps show where Steve Weitman may publish in the future.
Co-authors
The 25 scholars most cited alongside Steve Weitman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 522 | |
| 2 | The cationic porphyrin TMPyP4 down-regulates c-MYC and human telomerase reverse transcriptase expression and inhibits tumor growth in vivo. | 2002 | 334 |
| 3 | 2006 | 226 | |
| 4 | 2004 | 225 | |
| 5 | Development of SU5416, a selective small molecule inhibitor of VEGF receptor tyrosine kinase activity, as an anti-angiogenesis agent. | 2000 | 205 |
| 6 | A phase I study of irinotecan in pediatric patients: a pediatric oncology group study. | 2001 | 104 |
| 7 | 2007 | 101 | |
| 8 | 2016 | 94 | |
| 9 | 2002 | 84 | |
| 10 | 2018 | 82 | |
| 11 | 2002 | 70 | |
| 12 | 2006 | 62 | |
| 13 | Enhanced antitumor activity of 6-hydroxymethylacylfulvene in combination with irinotecan and 5-fluorouracil in the HT29 human colon tumor xenograft model. | 1999 | 61 |
| 14 | 2000 | 49 | |
| 15 | The new dioxolane, (-)-2'-deoxy-3'-oxacytidine (BCH-4556, troxacitabine), has activity against pancreatic human tumor xenografts. | 2000 | 47 |
| 16 | Elevated expression of DNA ligase I in human cancers. | 2001 | 47 |
| 17 | 2004 | 43 | |
| 18 | 2005 | 42 | |
| 19 | 2005 | 41 | |
| 20 | 2002 | 36 |
About Steve Weitman
Steve Weitman is a scholar working on Pharmaceutical Science, Oncology, Pediatrics, Perinatology and Child Health, Molecular Biology and Toxicology, having authored 34 papers that have together received 2.7k indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (12 papers), Pharmaceutical studies and practices (5 papers), Cancer Treatment and Pharmacology (4 papers), Drug Solubulity and Delivery Systems (3 papers), Advanced Drug Delivery Systems (3 papers), Bioactive Compounds and Antitumor Agents (2 papers), Sarcoma Diagnosis and Treatment (2 papers) and DNA Repair Mechanisms (2 papers). The work is most often cited by research in Pharmaceutical Science (407 citations), Molecular Medicine (275 citations), Cell Biology (198 citations), Biomaterials (163 citations) and Molecular Biology (734 citations). Steve Weitman has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Peter L. Bonate, Daniel D. Von Hoff, Rubén M. Muñoz, David J. Bearss, Haiyong Han, Laurence H. Hurley, Cory L. Grand, Zina Moldoveanu, Jiri F. Mestecky and Ramesh C. Rathi. Their work appears in journals such as Clinical Cancer Research, Cancer Chemotherapy and Pharmacology, Journal of Pediatric Hematology/Oncology, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.